Boule Diagnostics AB (BDABF) Stock Statistics & Valuation Metrics
Total Valuation
Boule Diagnostics AB has a market cap or net worth of $4.10M. The enterprise value is $293.09M.
- Market Cap
- $4.10M
- Enterprise Value
- $293.09M
Share Statistics
Boule Diagnostics AB has 38,833,103 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 38,833,103
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Boule Diagnostics AB’s return on equity (ROE) is -0.02 and return on invested capital (ROIC) is -0.73%.
- Return on Equity (ROE)
- -0.02
- Return on Assets (ROA)
- -0.01
- Return on Invested Capital (ROIC)
- -0.73%
- Return on Capital Employed (ROCE)
- 0.02
- Revenue Per Employee
- 2.45M
- Profits Per Employee
- -19.00K
- Employee Count
- 200
- Asset Turnover
- 1.04
- Inventory Turnover
- 4.68
Valuation Ratios
The current PE Ratio of Boule Diagnostics AB is -2.31. Boule Diagnostics AB’s PEG ratio is 0.05.
- PE Ratio
- -2.31
- PS Ratio
- 0.09
- PB Ratio
- 0.24
- Price to FCF
- 1.91
- Price to Operating Cash Flow
- 1.49
- PEG Ratio
- 0.05
Income Statement
In the last 12 months, Boule Diagnostics AB had revenue of 489.70M and earned -3.80M in profits. Earnings per share was -0.10.
- Revenue
- 489.70M
- Gross Profit
- 213.80M
- Operating Income
- 4.52M
- Pretax Income
- 5.90M
- Net Income
- -3.80M
- EBITDA
- 23.12M
- Earnings Per Share (EPS)
- -0.10
Cash Flow
In the last 12 months, operating cash flow was 26.90M and capital expenditures -5.90M, giving a free cash flow of 21.00M billion.
- Operating Cash Flow
- 26.90M
- Free Cash Flow
- 21.00M
- Free Cash Flow per Share
- 0.54
Dividends & Yields
Boule Diagnostics AB pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 54.08%
- Earnings Yield
- -44.29%
Important Dates
Boule Diagnostics AB upcoming earnings date is Feb 10, 2027, Before Open (Not Confirmed).
- Last Earnings Date
- Oct 23, 2026
- Next Earnings Date
- Feb 10, 2027
- Ex-Dividend Date
- ―
Financial Position
Boule Diagnostics AB as a current ratio of 1.09, with Debt / Equity ratio of 133.51%
- Current Ratio
- 1.09
- Quick Ratio
- 0.80
- Debt to Market Cap
- 1.01
- Net Debt to EBITDA
- 8.83
- Interest Coverage Ratio
- 0.28
Taxes
In the past 12 months, Boule Diagnostics AB has paid 9.70M in taxes.
- Income Tax
- 9.70M
- Effective Tax Rate
- 1.64
Enterprise Valuation
Boule Diagnostics AB EV to EBITDA ratio is 17.03, with an EV/FCF ratio of 11.52.
- EV to Sales
- 0.56
- EV to EBITDA
- 17.03
- EV to Free Cash Flow
- 11.52
- EV to Operating Cash Flow
- 8.99
Balance Sheet
Boule Diagnostics AB has $13.50M in cash and marketable securities with $216.50M in debt, giving a net cash position of -$203.00M billion.
- Cash & Marketable Securities
- $13.50M
- Total Debt
- $216.50M
- Net Cash
- -$203.00M
- Net Cash Per Share
- -$5.23
- Tangible Book Value Per Share
- $1.92
Margins
Gross margin is 43.07%, with operating margin of 1.95%, and net profit margin of -4.00%.
- Gross Margin
- 43.07%
- Operating Margin
- 1.95%
- Pretax Margin
- -2.95%
- Net Profit Margin
- -4.00%
- EBITDA Margin
- 3.30%
- EBIT Margin
- 0.09%
Analyst Forecast
The average price target for Boule Diagnostics AB is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -9.42%
- EPS Growth Forecast
- 74.83%
